Found: 29
Select item for more details and to access through your institution.
Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 1, p. 146, doi. 10.1002/ijc.11528
- By:
- Publication type:
- Article
Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 2, p. 238, doi. 10.1002/ijc.10921
- By:
- Publication type:
- Article
Histone deacetylase inhibitors suppress telomerase reverse transcriptase mrna expression in prostate cancer cells.
- Published in:
- International Journal of Cancer, 2002, v. 97, n. 5, p. 621, doi. 10.1002/ijc.10082
- By:
- Publication type:
- Article
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03212-5
- By:
- Publication type:
- Article
Birth Cohort Effects on Incidence of Lung Cancers: A Population-based Study in Nagasaki, Japan.
- Published in:
- Cancer Science, 2000, v. 91, n. 10, p. 960, doi. 10.1111/j.1349-7006.2000.tb00871.x
- By:
- Publication type:
- Article
A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 61, n. 2, p. 93, doi. 10.1159/000441486
- By:
- Publication type:
- Article
Phase I/II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced, Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 180, doi. 10.1159/000371870
- By:
- Publication type:
- Article
Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2890, doi. 10.1111/1759-7714.15097
- By:
- Publication type:
- Article
Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 14, p. 15117, doi. 10.1002/cam4.6184
- By:
- Publication type:
- Article
Secondary EML4–ALK-positive Lung Adenocarcinoma in a Patient Previously Treated for Acute Lymphoblastic Leukemia in Childhood: A Case Report.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 6, p. 593, doi. 10.1093/jjco/hyu028
- By:
- Publication type:
- Article
Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 17, p. 2300, doi. 10.1111/1759-7714.14055
- By:
- Publication type:
- Article
Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 2, p. 389, doi. 10.1111/1759-7714.13279
- By:
- Publication type:
- Article
Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 9, p. 1764, doi. 10.1111/1759-7714.13134
- By:
- Publication type:
- Article
Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 452, doi. 10.1111/1759-7714.12958
- By:
- Publication type:
- Article
Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 1, p. 51, doi. 10.1111/1759-7714.12535
- By:
- Publication type:
- Article
Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 6, p. 577, doi. 10.1111/1759-7714.12483
- By:
- Publication type:
- Article
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3765, doi. 10.1007/s00262-023-03528-x
- By:
- Publication type:
- Article
Treatment with gefitinib after erlotinib-induced liver injury: a case report.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 497, doi. 10.1007/s00280-014-2527-4
- By:
- Publication type:
- Article
Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 331, doi. 10.1007/s00280-010-1325-x
- By:
- Publication type:
- Article
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4221, doi. 10.3390/jcm10184221
- By:
- Publication type:
- Article
Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis Scoring.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1045, doi. 10.3390/jcm9041045
- By:
- Publication type:
- Article
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 3211, doi. 10.2147/OTT.S136837
- By:
- Publication type:
- Article
Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 5, p. 521, doi. 10.1016/j.cllc.2013.04.005
- By:
- Publication type:
- Article
Autoantibody to Heat Shock Protein Hsp40 in Sera of Lung Cancer Patients.
- Published in:
- Cancer Science, 2001, v. 92, n. 3, p. 316, doi. 10.1111/j.1349-7006.2001.tb01097.x
- By:
- Publication type:
- Article